KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 161 filers reported holding KITE PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,324,000 | +73.4% | 12,922 | 0.0% | 1.04% | +70.2% |
| Q2 2017 | $1,340,000 | -4.5% | 12,922 | -27.7% | 0.61% | +9.1% |
| Q1 2017 | $1,403,000 | +351.1% | 17,872 | +253.7% | 0.56% | +275.2% |
| Q4 2015 | $311,000 | +10.7% | 5,053 | 0.0% | 0.15% | +4.2% |
| Q3 2015 | $281,000 | -8.8% | 5,053 | 0.0% | 0.14% | +2.1% |
| Q2 2015 | $308,000 | +5.8% | 5,053 | 0.0% | 0.14% | +5.3% |
| Q1 2015 | $291,000 | – | 5,053 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|